These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 5482235)

  • 1. [Clinical evaluation of Provasan].
    Wodniecki J; Wolański A
    Wiad Lek; 1970 Oct; 23(20):1791-3. PubMed ID: 5482235
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R; Renda A
    Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of arteriopathies of limbs by xanthinol nicotinate].
    Elbaz C
    Phlebologie; 1969; 22(1):105-11. PubMed ID: 5775643
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of bencyclane in obliterative arterial diseases].
    Kusztos D
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1419+. PubMed ID: 5536658
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of induced cholesteremia and atherosclerosis in rabbits with cholestyramine, niacin and taurine.
    Burns MJ; Smith EF; Hoff EJ
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):601-8. PubMed ID: 810322
    [No Abstract]   [Full Text] [Related]  

  • 6. [Activity of a phospholipid association on serum lipoproteins and on cholesteremia].
    Rossi F; Bordo D
    Minerva Med; 1967 Jul; 58(57):2608-16. PubMed ID: 6057206
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
    Coscia M
    Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences with the treatment of peripheral vascular diseases with Xavin].
    Brücknerová O
    Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical considerations and functional data on the use of the association of kallikrein and meso-inositol hexanicotinate in the therapy of obliterating arteriopathy].
    Blasi A; Licciardello M
    Clin Ter; 1966 Jul; 38(2):121-58. PubMed ID: 5990194
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the cardiovascular dynamic changes induced by chorionic gonadotropin in vascular diseases].
    Melloni G; Fassini G
    Minerva Med; 1971 Mar; 62(25):1297-318. PubMed ID: 5552473
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic properties of xanthine nicotinate in the treatment of obliterating arteriopathies].
    Tardito E; Azzolini A; De Cristofaro A; Papacharalambus D
    Minerva Cardioangiol; 1972; 20(7):369-89. PubMed ID: 5050745
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prolonged intravenous and intra-arterial administration of large doses of Raubasine in peripheral arterial diseases].
    Raso AM; Silvestrini P
    Minerva Med; 1973 Mar; 64(19):961-9. PubMed ID: 4703313
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
    Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
    Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inositol hexanicotinate and its cholesteropenic effect].
    Crotte Zamora A; Romo López O
    Prensa Med Mex; 1974; 39(5-6):287-93. PubMed ID: 4612506
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of organic diseases of peripheral arteries with nicotinic acid derivatives].
    Liszewska D; Lukasik E
    Pol Tyg Lek; 1967 May; 22(21):794-6. PubMed ID: 6041002
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardilan in the treatment of obliterative diseases of peripheral arteries].
    Ginko T; Adamczyk R; Dyaczyńska A
    Wiad Lek; 1971 Jun; 24(12):1211-5. PubMed ID: 5561279
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complamine in obliterating peripheral circulatory disorders].
    Kusztos D; Bereczky M; Fono J
    Med Monatsschr; 1970 Mar; 24(3):127-8. PubMed ID: 5436974
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic possibilities in blood circulatory and lipid metabolism disorders].
    Schneider H
    Z Allgemeinmed; 1971 Dec; 47(36):1916-8. PubMed ID: 5003958
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experience with bencyclane in the treatment of vascular obliterations in the limbs].
    Krakovskij NI; Taranovic VA
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1435+. PubMed ID: 5536665
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results of treating obliterative diseases of the peripheral arteries with intra-arterial administrations of acetylcholine].
    Stepanova-Nikitina GG; Rage KM
    Sov Med; 1970; 33(8):45-9. PubMed ID: 5490077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.